iTeos Therapeutics, Inc. - ITOS Net Assets per Single Share

Graphic logo of iTeos Therapeutics (ITOS)

Anticipation of late-stage oncology drug trial results serves as the primary trigger for iTeos Therapeutics (ITOS), while operating expenses are already priced in. The company plans global market capture by expanding the belrestotug program in collaboration with GSK. Management is focused on integrating innovative antibodies into clinical practice. The estimated book value per share demonstrates capital resilience, where 11.08 indicates the current level of net assets.

iTeos Therapeutics Inc (ITOS): Share Book Value from 07/04/2022 to 09/14/2025

iteostherapeutics.com - analytical breakdowns and key metrics (ITOS)

- price and consensus price forecast:
Price Chart iTeos|ITOS - Average Forecast Price
- market capitalization data:
Market Value iTeos Therapeutics, Inc.|ITOS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share iTeos Therapeutics|ITOS - Net Asset Value|Market Capitalization to Book Value Ratio iteostherapeutics.com|ITOS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital iTeos Therapeutics|ITOS - Long-Term Debt to Capital|Short-Term Debt to Equity iTeos Therapeutics, Inc.|ITOS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio iTeos Therapeutics, Inc.
Fundamental company valuation:iTeos - ITOS
Manufactured products of iTeos Therapeutics, Inc.

This indicator is calculated as the ratio of equity to the number of shares outstanding, determining the net asset value per share. By analyzing the trend of the book value per share, an investor assesses the financial stability of iTeos Therapeutics (ITOS), where the capital volume directly depends on the efficiency of attracting R&D investments regardless of market cycles.

Competitors of iTeos Therapeutics (ITOS)

ARGX (Argenx) - Net Assets per Single Share|BNTX: Net Asset Value per Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Book Value per Share ATXS (Astria Pharma)|enGene Corp (ENGN) - Net Assets per Share|RAPT - Accounting Value per Share|Aerovate Therapeutics (JBIO) - Book Price of a Share|Book Value per Share ACRS (Aclaris Therapeutics, Inc.)|Net Asset Value per Share KYTX|Tiziana Life Sciences PLC - Net Assets per Single Share|Net Asset Value per Share CABA (Cabaletta Bio Inc)|Net Assets per Single Share VTYX|THTX - Net Assets per Share|Accounting Value per Share Avalo Therapeutics (AVTX)|Eledon Pharmaceuticals Inc. (ELDN) - Accounting Value of a Share|AGEN - Accounting Value per Share|Climb Bio, Inc (CLYM) - Book Price of a Share|ZURA - Book Value per Share|Accounting Value of a Share atyrpharma.com|Adagene - Book Value per Share|Net Asset Value per Share IMA (ikenaoncology.com)|Net Assets per Single Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|Connect Pharma - Book Value per Share|IMUX: Book Value per Share|Net Assets per Single Share atarabio.com (ATRA)|InflaRx (IFRX) - Share Book Value|Book Value per Share XFOR (X4 Pharma)|Net Asset Value per Share Adicet (ACET)|Accounting Value per Share CELU|Book Value per Share inmunebio.com INMB|Accounting Value per Share Barinthus Biotherapeutics plc (BRNS)|Book Price of a Share Kezar Life Sciences Inc. KZR|Book Value per Share SABS (SAB Biotherapeutics, Inc)|AKTX - Net Assets per Share|ENLV (enlivex.com) - Book Value per Share|QTTB (Q32 Bio) - Accounting Value per Share|GOVX: Net Assets per Single Share|Net Assets per Share Edesa Biotech Inc|IBIO (iBio Corp) - Book Value per Share|Net Assets per Share carismatx.com CARM|Accounting Value per Share XTL Biopharmaceuticals (XTLB)|Bolt Biotherapeutics Inc. - Book Price of a Share|HCWB (HCW Biologics Inc) - Net Assets per Single Share|APVO: Net Asset Value per Share|AIM ImmunoTech - Net Assets per Single Share|ADTX (Aditxt, Inc.) - Net Assets per Share|Net Assets per Single Share GRI Bio, Inc. GRI|Share Book Value xortx.com|Vyome Holdings (HIND) - Book Value per Share|Accounting Value of a Share Revelation Biosciences Inc (REVB)|Book Value per Share INDP (Indaptus)|BiondVax Pharmaceuticals - Book Value per Share|Net Assets per Single Share CalciMedica Corp (CALI)|AFMD: Accounting Value of a Share|ALLK (allakos.com) - Net Assets per Single Share|HOOKIPA Pharma (HOOK) - Accounting Value per Share|IGMS (IGM Biosciences Inc.) - Book Value per Share|Book Value per Share Ocean Biomedical Corp (OCEA)|TC Biopharm (TCBP) - Accounting Value per Share|Accounting Value of a Share thirdharmonicbio.com (THRD)